PolyNovo Limited logo

PolyNovo Limited

ASX:PNV.AX

Overview | Financials
Company Name PolyNovo Limited
Symbol PNV.AX
Currency AUD
Price 2.07
Market Cap 1,429,864,920
Dividend Yield 0%
52-week-range 1.3 - 2.78
Industry Medical Devices
Sector Healthcare
CEO Mr. Swami Raote BPHARM, M.B.A.
Website https://polynovo.com

An error occurred while fetching data.

About PolyNovo Limited

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair

Related Stocks

Clinuvel Pharmaceuticals Limited logo

Clinuvel Pharmaceuticals Limited

CUV.AX

13.7 AUD

Integral Diagnostics Limited logo

Integral Diagnostics Limited

IDX.AX

3.06 AUD

Regis Healthcare Limited logo

Regis Healthcare Limited

REG.AX

6.51 AUD

Oceania Healthcare Limited logo

Oceania Healthcare Limited

OCA.AX

0.665 AUD

Mesoblast Limited logo

Mesoblast Limited

MSB.AX

1.395 AUD

Estia Health Limited logo

Estia Health Limited

EHE.AX

3.08 AUD

Mayne Pharma Group Limited logo

Mayne Pharma Group Limited

MYX.AX

5.1 AUD

Incannex Healthcare Limited logo

Incannex Healthcare Limited

IHL.AX

0.041 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD